Beating both EPS and sales estimates by a wide margin, especially with a substantial year-over-year sales increase, typically leads to positive investor sentiment and could result in a short-term stock price increase. The significant outperformance in both key financial metrics indicates operational efficiency and market demand for Castle Biosciences' offerings, which is crucial information for investors.